Coeptis Therapeutics Holdings, Inc. Quarterly Accrued Liabilities, Current in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Coeptis Therapeutics Holdings, Inc. quarterly Accrued Liabilities, Current history and growth rate from Q4 2019 to Q2 2024.
  • Coeptis Therapeutics Holdings, Inc. Accrued Liabilities, Current for the quarter ending June 30, 2024 was $771K, a 80.8% increase year-over-year.
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $771K +$345K +80.8% Jun 30, 2024 10-Q 2024-08-16
Q1 2024 $719K +$424K +144% Mar 31, 2024 10-Q/A 2024-08-16
Q4 2023 $556K +$374K +205% Dec 31, 2023 10-Q 2024-08-16
Q3 2023 $567K Sep 30, 2023 10-Q/A 2024-08-16
Q2 2023 $427K Jun 30, 2023 10-Q/A 2024-03-25
Q1 2023 $295K Mar 31, 2023 10-Q/A 2024-03-25
Q4 2022 $182K -$17.1K -8.6% Dec 31, 2022 10-K/A 2024-08-16
Q4 2021 $199K +$194K +3883% Dec 31, 2021 10-K/A 2024-03-25
Q4 2020 $5K +$4.55K Dec 31, 2020 10-K/A 2022-02-02
Q4 2019 $450* Dec 31, 2019 10-K/A 2022-02-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.